MEDTOX BUPRENORPHINE TEST— 510(k) K100951
Substantially EquivalentMedtox Diagnostics, Inc.
FDA 510(k) clearance K100951 for MEDTOX BUPRENORPHINE TEST, Substantially Equivalent on 2010-10-18. Applicant: Medtox Diagnostics, Inc.. Device class: 2.
Clearance details
- Applicant
- Medtox Diagnostics, Inc.
- Product code
- Code DJG
- Device class
- Class 2
- Regulation
- 21 CFR 862.3650
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Burlington, NC, US
Recent devices under product code DJG
view allMore clearances from Medtox Diagnostics, Inc.
view all- K100023 — PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEM AND 12 DRUGS TEST SYSTEM
- K091454 — PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEM
- K080635 — MEDTOXSCAN
- K060351 — MEDTOX OXYCODONE
- K050394 — SURE-SCREEN AMPHETAMINE, BENZODIAZEPINE, COCAINE, METHAMPHETAMINE/MDMA, METHADONE, OPIATES, PHENCYCLIDINE & CANNABINOIDS
Data sourced from openFDA. This site is unofficial and independent of the FDA.